On December 23, 2021, the protocol for our open-label feasibility and safety study of MDMA-assisted group therapy for the treatment of posttraumatic stress disorder in Veterans (MPG1) was submitted to the Portland, Oregon, VA Institutional Review Board (IRB) by Dr. Chris Stauffer, Veteran’s Affairs (VA) Principal Investigator (PI).